baber/WOPTO huggingface dataset:
Patent NZ-563351-A (NZ)
Title: Powdered fuel cell
Inventor: LIN I-CHUAN
Filed: 2007-11-12
Abstract: A powdered fuel cell includes current collectors, fuel chambers, porous membranes, electrolyte chambers and gas diffusion electrodes. The porous membranes pass oxide the formed from the reacted fuel through the holes thereof and block the unreacted powdered fuel; the electrolyte chambers provide the storage space for electrolyte so as to conduct ions and provide the collection space for the reacted oxide; and the gas diffusion electrodes, each has one side surface thereof for an oxidizing agent incoming and outgoing and catalyzed to acquire electron and ion conduction, wherein one of the current collectors and one of the gas diffusion electrodes are connected by posts, saving outer wires and being connected directly to the anode and the cathode as a loop. Thus, a power supply being capable of electricity conversion and storage and movable is realized.
Patent NZ-583849-A (NZ)
Title: Display device with actuator selectively changing display indicators
Inventor: GROBBELAAR WARREN
IPC: G09F11/12
Filed: 2008-09-12
Abstract: A display device (56) which includes a housing (74), a plurality of separately movable indicators (70) in the housing, an electrically operable actuator (50) and a controller for controlling operation of the actuator (50). The actuator (50) is movable relative to the housing to a selected indicator where the selected indicator is independently movable by the actuator to a selected position (92) in order to display a selected symbol. A data display system, a display arrangement using the display device and a shelf with such a display arrangement fixed to its front edge is also disclosed.
Patent NZ-586259-A (NZ)
Title: Pyridine derivative substituted with heterocycle and phosphonoxymethyl group and antifungal agent containing the same
Inventor: MATSUKURA MASAYUKI
IPC: A61K31/661
Filed: 2008-12-26
Abstract: Disclosed is a phosphonoxymethyl pyridinyl compound of formula (I) where the substituents are as disclosed in the specification. Also disclosed are a pharmaceutical composition, a medicament or an antifungal agent comprising a compound of formula (I); and the use of a compound of formula (I) for the manufacture of a medicament
Patent NZ-589304-A (NZ)
Title: Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate
Inventor: COHEN DANIEL
IPC: A61P25/28
Filed: 2009-04-29
Abstract: Disclosed is the use of a composition comprising zonisamide, or a salt, or sustained release formulation thereof, in the manufacture of a medicament for the treatment of Alzheimer's disease.
Patent NZ-591816-A (NZ)
Title: An openable rodent management system with a hinged lid
Inventor: CINK JAMES H
IPC: A01M25/00
Filed: 2009-09-21
Abstract: A rodent management station 100 comprising a housing having an interior space and including a base 104 and a lid 106 that together at least in part define the interior space of the housing. The lid 106 is positionable relative to the base 104 between a closed configuration of the station 100 in which the interior space is substantially enclosed, and an opened configuration of the station 100 in which the interior space is accessible for servicing. The housing has an entry opening through which rodents enter the interior space of the housing. The lid 106 is hinged for hinged movement of the lid 106 relative to the base 104 between the opened and closed configurations of the station 100. The housing further has an internal partition structure configured to partition the interior space into a bait chamber having an entryway spaced from the entry opening of the housing. The partition structure is connected to the lid 106 for conjoint movement with the lid 106 relative to the base 104 upon movement of the lid 106 to the opened configuration of the station 100. The rodent management station 100 further comprises at least one of a trap and bait positionable within the interior space of the housing. The base 104 comprises a floor panel having a circumference and an inner surface on which rodents move within the interior space of the housing. The base 104 further comprises at least one upstanding wall extending upward relative to the floor panel about substantially less than the circumference of the floor panel such that a continuous circumferential segment of at least about 25 percent of the floor panel circumference is free from enclosure by the at least one upstanding wall in the opened configuration of the station 100.
Patent NZ-594669-A (NZ)
Title: Oral composition of Vorinostat
Inventor: WONG JEANNIE CHOW
IPC: A61P35/00
Filed: 2006-05-16
Abstract: ABSTRACT - 594669 Disclosed herein is a pharmaceutical composition for oral administration in capsule form comprising suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient in powder form, wherein about 100 mg of the active ingredient has an in vitro dissolution profile with a similarity factor (f2) of at least 56 to 100 compared to the reference dissolution profile of 52.7% dissolved at 10 minutes, 61.7% dissolved at 15 minutes, 67.7% dissolved at 20 minutes, 75.5% dissolved at 30 minutes, 82.6% dissolved at 45 minutes, and 87.0% dissolved at 60 minutes in vitro, wherein the total % volume of active ingredient with particle size less than about 105 microns is about 45-85% and the total % volume of active ingredient with particle size more than about 105 microns is about 55-15%, and optionally a pharmaceutically acceptable excipient that is a powder blend.
Patent NZ-601644-A (NZ)
Title: Cyclopropyl amine derivatives
Inventor: LIU HUAQING
IPC: A61K31/40
Filed: 2008-12-05
Abstract: Disclosed are crystalline salts of 2-[4-((1S,2S)-2-{ [(2S)-2-methylpyrrolidin-1-yl]methyl} cyclopropyl)phenyl]pyridazin-3(2H)-one, wherein the salts include crystalline 2-{ 4-[(1S,2S)-2-{ [(S)-2-methyl-pyrrolidin-1-yl]methyl)-cyclopropyl]-phenyl} -2Hpyridazin-3-one L-bitartrate monohydrate, crystalline 2-{ 4-[(1S,2S)-2-{ [(S)-2-methyl-pyrrolidin-1-yl]methyl)-cyclopropyl]-phenyl} -2Hpyridazin-3-one L-bitartrate anhydrate, crystalline 2-{ 4-[(1S,2S)-2-{ [(S)-2-methyl-pyrrolidin-1-yl]methyl)-cyclopropyl]-phenyl} -2Hpyridazin-3-one D-bitartrate dihydrate and crystalline 2-{ 4-[(1S,2S)-2-{ [(S)-2-methyl-pyrrolidin-1-yl]methyl)-cyclopropyl]-phenyl} -2Hpyridazin-3-one D-bitartrate anhydrate. These compounds are suitable for selectively modulating histamine-3 (H3) receptor activity and are particularly useful for treating and preventing a condition or disorder affecting attention-deficit hyperactivity, Alzheimer's disease, dementia, a condition or disorder affecting schizophrenia, cognitive deficits of schizophrenia, a condition or disorder affecting narcolepsy, sleep disorders, allergic rhinitis, asthma, or obesity.
Patent NZ-603931-A (NZ)
Title: Methods for deoxygenating biomass-derived pyrolysis oils
Inventor: ABRAHAMIAN JENNIFER F
IPC: C10L1/02
Filed: 2011-07-19
Abstract: Disclosed herein is a method (10) for deoxygenating treated biomass-derived pyrolysis oil, comprising the step of: exposing the treated biomass-derived pyrolysis oil to a catalyst having a neutral catalyst support (300), preferably selected from a carbon support, a non-alumina metal oxide support, or a support comprising a combination of carbon and non-alumina metal oxide.
Patent NZ-611827-A (NZ)
Title: Packaged solid body and production method thereof
Inventor: SEKIBA YUTAKA
IPC: B65D81/20
Filed: 2011-11-30
Abstract: A method for packaging a solid milk is disclosed. When a solid milk body is housed in a packaging material and sealed, a replacement gas in the form of carbon dioxide, having a property of being able to be absorbed in the solid body is intentionally introduced in the packaging material. Thereby, after the sealing, the replacement gas is absorbed in the solid milk body, and thus, a gap between the solid milk body and the packaging material becomes smaller, and the solid milk body is closely attached to the packaging material. When the absorption of the replacement gas is held in the equilibrium state, the volume of the package body remains constant. When the package body is opened though, a gap is generated between the solid milk body and the packaging material.
Patent NZ-618957-A (NZ)
Title: Service access authentication method and system
Inventor: NÄSLUND MATS
IPC: H04L29/06
Filed: 2012-06-13
Abstract: An access authentication system for authenticating a subscriber of a service is disclosed. The access authentication system comprises an operator access authentication system (101) and one or more private access authentication systems (102). The operator access authentication system (101) is an access authentication system operated by an operator. The private access authentication system (102) is an access authentication system operated by an entity different from an operator. Each private access authentication system (102) is communicatively connectable with the operator access authentication system (101). The operator access authentication system (101) is adapted to provide one or more authentication functions for facilitating authentication of subscribers of the service based on respective subscriber authentication data items associated with credentials of the subscriber. The credentials comprise subscriber data and data indicative of an authentication algorithm and its parameters. Each private access authentication system (102) operated by the subscriber is adapted to communicate one or more subscriber authentication data items associated with the credentials of the subscriber to said operator access authentication system (101). Each private access authentication system (102) operated by the subscriber is further adapted to communicate one or more verification data items. The verification data item comprises a remote attestation data item and is indicative of the private access authentication system (102) operating in at least one predetermined state, and facilitates determination whether the at least one predetermined state is trustable by the operator access authentication system (101).
Patent NZ-629161-A (NZ)
Title: Process for preparation of roflumilast
Inventor: CHEN YI-JING
IPC: C07D213/75
Filed: 2013-03-07
Abstract: Disclosed is a processes for the preparation of N-substituted benzamides having the formula (VIc). In some embodiments, the process for preparation of roflumilast and other pharmaceutically active species. Compounds, including intermediates for the synthesis of roflumilast (3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide), are also provided.
Patent NZ-703985-A (NZ)
Title: A ground stabilisation system, a support and a method of stabilising ground
Inventor: COLLIS SIMON PAUL
IPC: E02D3/12
Filed: 2013-07-22
Abstract: Disclosed is a ground stabilisation system that permits resinous material to exude into selected regions of surrounding soil at desired times, in a controllable manner in order to create a stabilised volume of soil. The ground stabilisation system includes: a delivery channel (10) that is closed at one end (12) and adapted to receive a grout or resinous material. The delivery channel (10) has at least one chamber. There is at least one valve (30) defining the at least one chamber and apertures (20) formed in the delivery channel wall. The delivery channel (10) is adapted to receive a concentric member (40), which in use passes through the at least one valve (30). The concentric member (40) is displaceable with respect to the delivery channel (10) such that the at least one valve (30) is selectively opened and closed to permit at least one of grout and resinous material to fill a selected one of the at least one chamber and exude via the selected apertures (20), into regions of surrounding soil to create a stabilised volume of soil bonded to the delivery channel (10). The at least one valve (30) is configured such that removal of the concentric member (40) from the at least one valve (30) acts to close the at least one valve (30), thereby sealing the at least one chamber. The method for soil consolidation is also disclosed.
Patent NZ-707213-A (NZ)
Title: Compositions and methods of treating pulmonary hypertension
Inventor: BELARDINELLI LUIZ
IPC: C07D317/46
Filed: 2011-10-14
Abstract: The disclosure relates to a combination therapy comprising a therapeutically effective amount of a selective type-A endothelin receptor antagonist (ERA) selected from the group consisting of ambrisentan, sitaxsentan and pharmaceutically acceptable salts thereof, and a therapeutically effective amount of a phosphodiesterase type 5 (PDE5) inhibitor selected from the group consisting of sildenafil, tadalafil, vardenafil and pharmaceutically acceptable salts thereof, wherein the weight ratio of the selective type-A ERA and the PDE5 inhibitor is in a range from about 1:1 to about 1:10. The disclosure also relates to the use of this combination for treating pulmonary hypertension.
Patent NZ-707895-A (NZ)
Title: Formulation for bispecific t-cell engagers (bites)
Inventor: OLBRICH CARSTEN
IPC: C07K16/30
Filed: 2013-11-05
Abstract: The present invention relates to stable pharmaceutical compositions which contain polypeptides having at least two antigen binding domains and are particularly suitable for subcutaneous administration. In particular, a liquid pharamaceutical composition comprising: a polypeptide, TRIS and phosphate, the polypeptide comprising the amino acid sequence reproduced in SEQ ID NO: 8, characterized in that the composition contains the polypeptide in a concentration of from 0.5 µg/ml to 3.0 mg/ml, that the composition contains 100 mM TRIS and 50 mM phosphate, that the pH of the composition is about 6.0 and that the composition contains 0.04% polysorbate 80. The invention provides liquid compositions which minimize the formation of unwanted polypeptide aggregates (dimers and/or multimers). The present invention further provides a method of minimizing the aggregation of polypeptides having antigen binding domains in liquid compositions.
Patent NZ-724269-A (NZ)
Title: Data communication device and method
Inventor: JONES LEE
IPC: H04L12/26
Filed: 2014-09-05
Abstract: The present invention relates to a data communication device and method for recording and transmitting data concerning conditions within or pertaining to a transportation container, such as a controlled environment transportation container. The communication device includes a processor, a memory, a port for receiving the data, a first power source, a communication module operatively coupled to the first power source, and a computer program stored in the memory. The program is operative, when executed on the processor, to store the received data in the memory and to cause the communication module to periodically power on, attempt for a specified time period to establish a network connection, and in the event of a successful connection, communicate data stored in the memory over the network, and to power off. The processor independently operates to switch between sleep and active modes in accordance with a system timer or receipt of data, and to determine whether the communication module is to be activated.
Patent NZ-725249-A (NZ)
Title: Metal smart card with dual interface capability
Inventor: JOHN HERSLOW
IPC: G06K19/067
Filed: 2015-07-08
Abstract: A dual interface smart card having a metal layer includes an IC module, with contacts and RF capability, mounted on a plug, formed of non RF impeding material, between the top and bottom surfaces of the metal layer. The plug provides support for the IC module and a degree of electrical insulation and isolation from the metal layer. The resultant card can have contact and contactless operating capability and an entirely smooth external metal surface except for the contacts of the IC module.
Patent NZ-732360-A (NZ)
Title: Modified cry1ca toxins useful for control of insect pests
Inventor: LIN GAOFENG
IPC: A01H1/00
Filed: 2015-12-16
Abstract: The subject invention concerns Bacillus thuringiensis modified Cry1Ca insecticidal toxins and the polynucleotide sequences which encode these toxins. Uses in transgenic plants are described as are methods for protecting crops from insect pest damage. In one embodiment, there is provided a modified Cry1Ca toxin comprising an Ala54 modification that provides for resistance to chymotrypsin cleavage.
Patent NZ-732843-A (NZ)
Title: Drawers and components for drawers
Inventor: MILES SHANE
IPC: A47B88/437
Filed: 2015-12-07
Abstract: A drawer system that includes a drawer cabinet (116) and a drawer (112) mounted in the cabinet for forward and backward travel. The cabinet having two opposed, spaced apart side walls and at least two lower wheels (185, 186, 187) mounted to each side wall. The two lower wheels are spaced apart in the intended direction of travel of the drawer. The drawer has two opposed spaced apart side panels and at least two lower wheels mounted to each side panel which are spaced apart in the intended direction of travel of the drawer. A runner (113) is mounted on the lower cabinet wheels of each side wall for forward and backward travel relative to said cabinet via a first track. Each runner includes a second track engaged by the spaced apart lower drawer wheels for forward and backward travel of said drawer relative to said runner. Each spaced apart side walls of the cabinet include upper guide means on or mounted to each side wall and spaced above the lower wheels. Each spaced apart side panels of the drawers include upper guide means mounted to or on each side panel and spaced above the lower wheels. The invention has particular application to drawers intended for use with heavy loads and drawers or drawer cabinets required for use in dirty or dusty locations. One particular application of the present invention is in drawer cabinets of the type used in vehicles for storing tools, recovery kits, spare parts and the like.
Patent NZ-735661-A (NZ)
Title: A Propolis Mat Cleaner and Method of Use
Inventor: Ian Boyer
IPC: A01K51/00
Filed: 2017-09-20
Abstract: Described herein is a propolis mat cleaner apparatus and method of use that uses vibration, hammering and collection mat movement to separate propolis from a collection mat. Art methods of removing propolis from collection mats have largely been manual, for example, by hand shaking mats to break off propolis. Manual methods like this are slow and not very efficient at separating propolis from the mats. An apparatus is described herein to automatically retain a propolis collection mat and separate propolis from the mat, the apparatus comprising: a retention mechanism to releasably retain and convey a collection mat; and a separation mechanism to both vibrate and hammer the collection mat while being retained and conveyed relative to the separation mechanism, the separation mechanism separating propolis from the collection mat as a result of the combined action of vibration and hammering of the collection mat. Also described is a method of separating propolis from a collection mat is described, the method comprising the steps of: retaining a collection mat in a retention mechanism; conveying the collection mat via the retention mechanism past a separation mechanism, the separation mechanism both vibrating and hammering the collection mat as it is passes the separation mechanism.
Patent NZ-746140-A (NZ)
Title: Ambrisentan for use in the treatment of acute renal failure
Inventor: NAVARRO IKER
IPC: A61K31/00
Filed: 2017-03-20
Abstract: Ambrisentan and formulations thereof for use in the treatment and prevention of acute renal failure associated with renal vasoconstriction.
Patent NZ-750751-A (NZ)
Title: Glove stripping apparatus and method as well as a production line and production process using the glove stripping apparatus and method
Inventor: STOLLERY JONATHAN WILLIAM
IPC: B29C37/00
Filed: 2017-08-25
Abstract: A glove stripping apparatus (15) for fully stripping a partially stripped elastomeric dip-moulded glove (2) from a hand-shaped dip-moulding former (4) comprises a gripping device (25) relatively movable in a horizontal direction with respect to a downwardly hanging cuff end portion (10), a gripping actuator (31, 32) and a controller for controlling the operation of the actuators. The relative movement of the gripping device and the downwardly hanging cuff end portion is driven by the stripping actuators. The gripping device has first and second gripping members (24, 26) horizontally movable relative to each other by the gripping actuators. The gripping members provide opposed gripping surfaces (34, 36) for gripping the cuff end portion. The first gripping member and the second gripping member initially provide a horizontally extending gap between the gripping surfaces which receives the cuff end portion. The gripping members are moved to reduce the gap until the cuff end portion is restrained between the gripping surfaces with a beaded cuff end (3) of the glove being below the gap. The gripping members are moved horizontally (51 ) together away from the line of formers so that the cuff end portion moves upwards relative to the gap until the beaded cuff end (3) is caught by the gap. The horizontal movement of the cuff end portion is translated substantially vertical stripping movement off the former by a horizontally elongate abutment (55) extending above the level of the two gripping members (24, 26). The horizontal movement is then continued until the glove is fully stripped from the dip-moulding former. The benefit of the is that the automatic registration of the cuff beaded end 3 with the opposed gripping surfaces (34, 36) helps to ensure that the cuff end is then deposited in a known and predicable manner, for example with a separation from an edge (71, 71’) of the receiving surface (70), that is highly (30) consistent and repeatable from glove to glove, as shown in Figure 3. These factors help to make further processing of the gloves more consistent and help to optimise the way gloves lie one on another when formed into a stack.
Patent NZ-755382-A (NZ)
Title: Prepuce extruding, cutting, hemostasis, and healing assembly using ultrasonic wave
Inventor: SHANG JINGJING
IPC: A61B17/326
Filed: 2018-01-11
Abstract: A prepuce extruding, cutting, hemostasis, and healing assembly using ultrasonic wave. Ultrasonic wave is applied in extruding, cutting, hemostasis, and healing of prepuce at a conjunction of internal and external tissues. The assembly comprises an ultrasonic generating device (Z), a transmission device (3) and a circumcision device (not shown). The ultrasonic generating device (Z) is used for generating ultrasonic waves, is connected to the transmission device (3) and can send the ultrasonic waves to the transmission device (3). The transmission device (3) is connected to the circumcision device and can send the ultrasonic waves to the circumcision device. The circumcision device is used for extruding and cutting a prepuce and/or performing hemostasis and/or healing of wounds. In this way, circumcision can be completed within just several seconds, and immediate healing can be achieved, preventing bleeding during and after a surgery, preventing infectious diseases, and reducing the risk of bleeding or nail falling/ring falling of a patient subjected to the circumcision due to physiological erection.
Patent PT-102361-A (PT)
Title: Method for obtaining aryl ethers and thio ethers, involves reacting thiol or phenol with composition containing halogenated derivative
Inventor: PEREIRA MARIA FLORBELA BENTO M
IPC: B01J19/08
Filed: 1999-09-22
Abstract: Aryl ethers and thio ethers are obtained by the use of microwave radiation, by reaction of thiol or phenol with a composition containing a halogenated derivative or similar.